Angela Rohrbaugh, APRN
Family · Hollywood, FLNPI 1376843565
Payments from drug & device makers
Across 73 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$198
- Boehringer Ingelheim$196
- Novo Nordisk$177
- Lilly USA, LLC$128
- Currax Pharmaceuticals LLC$104
- Exact Sciences$88
- plus $577 from 12 others
What the payments were for
- Food & beverage$1,44198%
- Education$252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 9 | $198 |
| Boehringer Ingelheim | 9 | $196 |
| Novo Nordisk | 8 | $177 |
| Lilly USA, LLC | 8 | $128 |
| Currax Pharmaceuticals LLC | 6 | $104 |
| Exact Sciences | 3 | $88 |
| Sanofi-aventis U.S. LLC | 4 | $86 |
| Amgen | 5 | $85 |
| AstraZeneca | 4 | $76 |
| Pfizer | 4 | $73 |
| Mannkind Corporation | 4 | $72 |
| Abbott | 2 | $47 |
| Amarin Pharma, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Johnson & Johnson | 1 | $19 |
| IBSA Pharma Inc. | 1 | $18 |
| AbbVie | 1 | $14 |
How this compares
$1,466 in reported general payments places this provider in the 75th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $41,491 |
| OzempicSemaglutide | 31 | $40,760 |
| JardianceEmpagliflozin | 21 | $36,530 |
| TrulicityDulaglutide | 19 | $22,388 |
| XareltoRivaroxaban | 13 | $18,849 |
| FarxigaDapagliflozin Propanediol | 14 | $15,513 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $13,034 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $7,360 |
| NovologInsulin Aspart | 16 | $2,506 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,475 |
| SynthroidLevothyroxine Sodium | 22 | $2,417 |
| Atorvastatin Calcium | 306 | $2,367 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,937 |
| Rosuvastatin Calcium | 111 | $1,163 |
| Ipratropium Bromide | 27 | $864 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $177 | $43,26747 claims |
| PfizerEliquis | $73 | $41,49131 claims |
| Boehringer IngelheimJardiance | $196 | $36,53021 claims |
| Lilly USA, LLCTrulicity | $128 | $22,38819 claims |
| Johnson & JohnsonXarelto | $19 | $18,84913 claims |
| AstraZenecaFarxiga | $76 | $15,51314 claims |
| AbbVieSynthroid | $14 | $2,41722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 14,618 family providers in Florida.
Other family in Hollywood
- Marisol RiveraHollywood$65K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.